Related Experiment Videos
Naltrexone: a clinical perspective
Abstract:
The narcotic antagonist naltrexone was studied in over 300 opiate addicts. Patient selection was a major factor in determining retention and treatment outcome. Treatment time ranged from 1 week to over a year (mean = 2 months). A quarter of the study patients had multiple treatment episodes. Stabilized patients had few side effects, except for occasional nausea and abdominal cramps. Almost half the subjects tested naltrexone by using opiates at least once; all reported satisfactory narcotic blockade. Very few subjects switched to nonopiates to get high, although several did increase their alcohol consumption during the first weeks of therapy. One-third of subjects contacted in a follow-up study were opiate-free 6 months after stopping naltrexone, indicating a successful short-term treatment modality.
Insights
Naltrexone, a narcotic antagonist, showed effectiveness in blocking opiate effects for addicts. While some patients increased alcohol use, one-third remained opiate-free six months post-treatment, indicating short-term success.
Area of Science:
- Pharmacology
- Addiction Medicine
- Clinical Psychology
Background:
- Opiate addiction is a significant public health issue.
- Naltrexone is an opioid antagonist used in addiction treatment.
- Understanding naltrexone's efficacy and patient factors is crucial for treatment success.
Purpose of the Study:
- To evaluate the effectiveness of naltrexone in treating opiate addiction.
- To identify factors influencing patient retention and treatment outcomes.
- To assess side effects and relapse patterns during naltrexone therapy.
Main Methods:
- A study involving over 300 opiate-addicted patients.
- Treatment duration varied, with a mean of two months.
- Patient selection criteria were analyzed for their impact on outcomes.
Main Results:
- Patient selection significantly impacted retention and outcomes.
- Most patients experienced satisfactory narcotic blockade when tested.
- One-third of patients were opiate-free six months after naltrexone cessation.
Conclusions:
- Naltrexone demonstrates potential as a short-term treatment modality for opiate addiction.
- Careful patient selection is vital for optimizing naltrexone treatment.
- Further research may explore long-term efficacy and management of increased alcohol consumption.